H. A. von Recum

This paper investigates the refilling capacity of PLGA implants, finding that even unmodified PLGA can refill with unassociated drugs, contrary to expectations.

This paper develops a sustained release platform using β-CD microparticles to extend the delivery of the 15-PGDH inhibitor SW033291 beyond one week.

This paper develops a refillable PMMA bone cement composite for localized, multi-window chemotherapy of bone cancer, showing sustained drug release and improved cytotoxicity compared to conventional methods.

This paper develops a cyclodextrin polyester with a chelator-based crosslinker for stent-based drug delivery, showing controlled drug release and stable coating on metal stents.

This paper introduces a method to inactivate pathogens using polymer additives in face masks, demonstrating effectiveness against both Gram-positive and Gram-negative bacteria.

This paper demonstrates that tethering small-molecule drugs to high-affinity groups improves their affinity for cyclodextrin polymers, enhancing drug delivery without compromising cellular activity.

This study uses nonthermal plasma treatment to enhance coating quality and durability on hydrophobic polymer surfaces by improving wettability and interfacial bonding.

This study examines how nonthermal plasma treatment affects both surface and bulk properties of polymeric implants, finding benefits for biological fouling resistance but risks of material embrittlement with prolonged exposure.

This paper develops a combination-antibiotic PMMA composite system that extends antimicrobial activity duration and allows post-implantation refilling, though it slightly reduces mechanical properties.

This study shows that cyclodextrin polymers enable long-term drug delivery with size-tunable cellular uptake and size-independent release of lenalidomide for macrophage targeting.